15 Best Low Volatility Blue Chip Stocks to Buy Now
On April 7, RBC Capital raised the firm’s price recommendation on Nutrien Ltd. (NYSE:NTR) to $85 from $80. It reiterated an Outperform rating on the shares.
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 8,866,207 | $1,834,861,808 | +5% | 0.63% |
| 2. | GQG Partners Rajiv Jain | 7,752,266 | $1,604,336,241 | +29% | 2.64% |
| 3. | AQR Capital Management Cliff Asness | 3,876,221 | $802,183,859 | -11% | 0.42% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,668,263 | $759,147,029 | +3% | 0.69% |
| 5. | 3,072,600 | $635,874,570 | -14% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $206.15 | 1,250 | $257,687.50 | 1,849 | 2025-11-26 | Filing | |
| $145.53 | 100 | $14,553.00 | 250 | 2024-04-30 | Filing | |
| $147.22 | 1,000 | $147,220.00 | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | $63,843.00 | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | $706,399.00 | 5,000 | 2019-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $247.87 | 4,075 | $1,010,070.25 | 23,682 | 2026-02-27 | Filing | |
| $245.66 | 1,322 | $324,762.52 | 25,447 | 2026-02-20 | Filing | |
| $242.70 | 20,521 | $4,980,446.70 | 25,698 | 2026-02-17 | Filing | |
| $243.71 | 22,191 | $5,408,168.61 | 25,020 | 2026-02-13 | Filing | |
| $243.76 | 19,368 | $4,721,143.68 | 25,020 | 2026-02-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,555,687 | $340,595,507 | 0.69% | |
| 2. | 320,096 | $78,244,378 | 7.97% | |
| 3. | 237,043 | $57,942,750 | 4.22% | |
| 4. | 157,263 | $38,441,358 | 0.97% | |
| 5. | 154,290 | $37,498,614 | 1.17% |
News See All
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
15 Best Stocks to Buy According to Billionaire Ray Dalio
Billionaire Ray Dalio recently took to social networking platform X to outline his thoughts on the current geopolitical situation and the impact it will have on global markets.
13 Best Diversified Dividend Stocks to Buy Right Now
Diversified stocks refer to companies that operate across multiple sectors, industries, or regions.
Johnson & Johnson (JNJ) Benefits from Growth Pipeline and Strength Across Key Therapeutic Areas
Ariel Investments, an investment management company, released its "Ariel Focus Fund" fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Iran Conflict Rattles Stocks — Jim Cramer’s Game Plan and 9 Stock Calls
In this article, we will look at everything Jim Cramer said regarding his latest game plan as the oil-shock-driven sell-off continues.
Dividend Kings and Aristocrats List: 32 Biggest Stocks
The markets have been churning all year. This picked up after the start of the Iran war on February 28 and the rally in crude oil prices.
Punitive Damages Award Worth $950 Million Overturned Against Johnson & Johnson (JNJ), $16M Talc Verdict Stands
Regarding a mesothelioma case, where a woman allegedly died from cancer caused by the company’s talc products, Johnson & Johnson (NYSE:JNJ) faced a setback on March 16, 2026.
11 Most Overvalued Companies According to the Media
On March 14, 2026, according to Reuters, the Russell 2000 finished at its lowest point of the year, while the S&P 500, the Dow, and the Nasdaq all posted weekly declines, with Wall Street’s major indexes...
Johnson & Johnson (JNJ) Advances Bladder Cancer Treatment with 89% Response Rate
Johnson & Johnson (NYSE:JNJ) ranks among the best most active stocks to buy right now.
Hedge Fund Resource Center